Connect with us

Health

Post-Vax Clot Case Supports Angiomax Use – MedPage Today

This might be a good non-heparin alternative, docs say

Published

on

Article feature image

Bivalirudin (Angiomax) worked for one of the very rare cases of blood clots with low platelets after vaccination against COVID-19, researchers reported.
The 40-year-old woman presented with a headache on the same day that the CDC and FDA hit pause on use of the Johnson & Johnson vaccine over risk of what’s being dubbed vaccine-induced thrombotic thrombocytopenia (VITT) or thrombosis with thrombocytopenia syndrome (TTS).
She developed a headache, sinus pressure, myalgias, and sore throat with tonsillar…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Next two weeks critical to preventing a COVID-19 outbreak in NSW – ABC News
Article feature image
Sleeping six to seven hours a night associated with more favorable heart health – News-Medical.Net